Albany Int'l (AIN) Form 4: 6,905 RSUs Vest for President AEC
Rhea-AI Filing Summary
Christopher Eric Stone, an officer (President AEC) of Albany International Corp (AIN), received shares when Restricted Stock Units (RSUs) vested. On 08/12/2025, 6,905 RSUs granted under the 2023 Plan vested and were distributed as shares, and 1,975 shares were withheld to satisfy tax withholding at $62.80 per share, leaving 4,930 shares beneficially owned following the transaction. The filing also discloses unvested RSU awards: a tranche of RSUs with scheduled vesting in August 2026 and August 2027 from the August 12, 2024 grant, plus separate RSU grants vesting March 1 in 2025–2028 as detailed in the footnotes. The activity reflects routine compensation vesting and tax withholding.
Positive
- Officer received 6,905 shares via RSU vesting, increasing direct ownership and aligning executive and shareholder interests
- Clear multi-year vesting schedules disclosed, showing retention incentives remain in place
Negative
- None.
Insights
TL;DR: Routine officer compensation vesting; modest net increase in direct shares after tax withholding.
The Form 4 reports standard employee equity compensation mechanics rather than discretionary open-market trading. The distribution of 6,905 vested RSUs with 1,975 shares withheld for taxes at $62.80 is a common net-delivery outcome: gross equity grant converted to shares, netted for withholding obligations, producing 4,930 new directly owned shares. This alters insider holdings modestly but does not indicate a change in corporate control or a sale of shares to third parties. For investors, the filing signals executive alignment via equity compensation and shows remaining multi-year vesting schedules from multiple grants.
TL;DR: Compensation-driven vesting maintains executive alignment; no governance red flags disclosed.
The disclosure details scheduled vesting and tax-withholding mechanics for RSUs granted under the company plan. Multiple tranches remain unvested, with clear vesting schedules in 2026 and 2027 and separate March-vesting tranches tied to a February 2025 grant. The filing was executed by an attorney-in-fact, which is typical for routine insider reporting. There are no indications of accelerated vesting, related-party transfers, or unusual dispositions that would raise governance concerns.